121 related articles for article (PubMed ID: 6786827)
1. Plasma levels of levonorgestrel in women during longterm use of norplant.
Croxatto HB; Díaz S; Miranda P; Elamsson K; Johansson ED
Contraception; 1981 Feb; 23(2):197-209. PubMed ID: 6786827
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of levonorgestrel in women during longterm use of Norplants.
Croxatto HB; Díaz S; Miranda P; Elamsson K; Johansson ED
Contraception; 1980 Dec; 22(6):583-96. PubMed ID: 6971208
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
5. Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
Kurunmäki H; Toivonen J; Lähteenmäki PL; Luukkainen T
Contraception; 1984 Nov; 30(5):431-42. PubMed ID: 6440739
[TBL] [Abstract][Full Text] [Related]
6. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
7. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
[TBL] [Abstract][Full Text] [Related]
8. [Long-term follow-up of women treated with contraceptive implants of levonorgestrel Norplant].
Díaz S; Pavez M; Miranda P; Quinteros E; Croxatto HB
Rev Chil Obstet Ginecol; 1989; 54(5):323-31; discussion 331-2. PubMed ID: 2518764
[TBL] [Abstract][Full Text] [Related]
9. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
Affandi B; Cekan SZ; Boonkasemsanti W; Samil RS; Diczfalusy E
Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of women treated with Norplant implants.
Díaz S; Pavez M; Miranda P; Johansson ED; Croxatto HB
Contraception; 1987 Jun; 35(6):551-67. PubMed ID: 3117490
[TBL] [Abstract][Full Text] [Related]
11. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
12. Norplant contraceptive implants: rods versus capsules.
Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
[TBL] [Abstract][Full Text] [Related]
13. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
14. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
Haukkamaa M
Contraception; 1986 Jun; 33(6):559-65. PubMed ID: 3095023
[TBL] [Abstract][Full Text] [Related]
15. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
[TBL] [Abstract][Full Text] [Related]
16. Androgen levels in women using Norplant implants.
Olsson SE; Odlind V; Johansson E
Contraception; 1986 Aug; 34(2):157-67. PubMed ID: 2946553
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity is unaltered by the use of the Norplant subdermal implant contraceptive.
Koopersmith TB; Lobo RA
Contraception; 1995 Mar; 51(3):197-200. PubMed ID: 7621688
[TBL] [Abstract][Full Text] [Related]
18. Immediate postpartum insertion of the norplant contraceptive device.
Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel concentrations in maternal and infant serum during use of subdermal levonorgestrel contraceptive implants, Norplant, by nursing mothers.
Shaaban MM; Odlind V; Salem HT; Abdullah KA; Gomaa AA
Contraception; 1986 Apr; 33(4):357-63. PubMed ID: 3089681
[TBL] [Abstract][Full Text] [Related]
20. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
Diaz S; Pavez M; Miranda P; Robertson DN; Sivin I; Croxatto HB
Contraception; 1982 May; 25(5):447-56. PubMed ID: 6809423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
